These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 399942)

  • 1. Evidence against acetone-soluble renin inhibitors in normal human plasma.
    Druilhet RE; Overturf ML; Hinshaw RA; Kirkendall WM
    Hypertension; 1979; 1(2):98-105. PubMed ID: 399942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of renin reactivity by lipids extracted from normal, hypertensive, and uremic plasma.
    Kotchen TA; Talwalker RT; Miller MC; Welch WJ
    J Clin Endocrinol Metab; 1976 Nov; 43(5):971-81. PubMed ID: 186481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the existence of an acetone soluble renin inhibiting factor in normal human plasma.
    Kotchen TA; Talwalkar RT; Kotchen JM; Miller MC; Welch WJ
    Circ Res; 1975 Jun; 36(6 Suppl 1):17-27. PubMed ID: 1132076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the in vitro renin reaction by circulating neutral lipids.
    Kotchen TA; Talwalkar RT; Welch WJ
    Circ Res; 1977 Oct; 41(4 Suppl 2):46-8. PubMed ID: 902372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic activity of renin in plasma of normal and uraemic subjects.
    Kotchen TA; Guyenne TT; Corvol P; Menard J
    Clin Sci (Lond); 1984 Sep; 67(3):365-8. PubMed ID: 6380890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of renin inhibitors in normal and uremic plasma.
    Kotchen TA; Talwalkar RT; Kaul K
    J Lab Clin Med; 1985 Mar; 105(3):286-93. PubMed ID: 3882863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous measurement of PRA, PRC and PRR and the relation of renin reaction rate to renin substrate concentration.
    Gordon DB; Sachin IN
    Clin Exp Hypertens (1978); 1980; 2(1):65-87. PubMed ID: 6998679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac angiotensinogen and its local activation in the isolated perfused beating heart.
    Lindpaintner K; Jin MW; Niedermaier N; Wilhelm MJ; Ganten D
    Circ Res; 1990 Sep; 67(3):564-73. PubMed ID: 2204498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human renin by rat plasma. Rat angiotensinogen is a competitive inhibitor of the human renin-substrate interaction.
    Gahnem F; Sealey JE; Atlas SA; Laragh JH
    Am J Hypertens; 1992 Aug; 5(8):495-501. PubMed ID: 1388958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological and immunopathological consequences of active immunization of spontaneously hypertensive and normotensive rats against murine renin.
    Michel JB; Sayah S; Guettier C; Nussberger J; Philippe M; Gonzalez MF; Carelli C; Galen FX; Menard J; Corvol P
    Circulation; 1990 Jun; 81(6):1899-910. PubMed ID: 2188756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin reactivity in plasma of patients with normal renin and low renin essential hypertension.
    Brooks CS; Talwalker RT; Kotchen TA
    J Clin Endocrinol Metab; 1977 Feb; 44(2):322-9. PubMed ID: 838842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin reactivity, renin activity and renin concentration in patients with normal and low renin essential hypertension.
    McDonald WJ; Cohen EL; Conn JW
    J Clin Endocrinol Metab; 1977 Oct; 45(4):685-90. PubMed ID: 914973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased enzymatic activity of renin and hyperlipidemia.
    Kotchen TA; Talwalkar RT
    Am J Physiol; 1981 Jan; 240(1):E60-4. PubMed ID: 7006415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver angiotensinogen synthesis and release during captopril treatment in sodium-depleted rats.
    Jaramillo HN; Sambhi MP; Bouhnik J; Corvol P; Menard J
    Endocrinology; 1987 Apr; 120(4):1384-90. PubMed ID: 3030698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin substrate (angiotensinogen) preparations in the determination of prorenin and renin: evidence for extrarenal plasma prorenin and its renal "convertase".
    Purdon AD; Loh AY; Osmond DH
    Can J Physiol Pharmacol; 1987 Nov; 65(11):2319-28. PubMed ID: 3329567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances in the clinical study of the renin system. Reference values and conditions of validity].
    Plouin PF; Chatellier G; Guyene TT; Vincent N; Corvol P
    Presse Med; 1989 May; 18(18):917-21. PubMed ID: 2524779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.
    van den Heuvel M; Batenburg WW; Jainandunsing S; Garrelds IM; van Gool JM; Feelders RA; van den Meiracker AH; Danser AH
    J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat.
    Campbell DJ; Lawrence AC; Towrie A; Kladis A; Valentijn AJ
    Hypertension; 1991 Dec; 18(6):763-73. PubMed ID: 1660448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential changes in the renin--angiotensin--aldosterone systems and plasma progesterone concentration in normal and abnormal human pregnancy.
    Weinberger MH; Kramer NJ; Petersen LP; Cleary RE; Young PC
    Perspect Nephrol Hypertens; 1976; 5():263-9. PubMed ID: 1005040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A circulating renin activator in essential hypertension.
    Sambhi MP; Eggena P; Barrett JC; Tuck M; Wiedeman CE; Thananopavarn C
    Circ Res; 1975 Jun; 36(6 Suppl 1):28-37. PubMed ID: 805672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.